Biologic agents in experimental autoimmune uveitis

被引:0
|
作者
Gian Paolo Giuliari
Ama Sadaka
David M. Hinkle
机构
[1] Centro de Cirugía Oftalmológica (CECOF),Department of Ophthalmology
[2] School of Medicine,undefined
[3] Domingo Luciani Hospital,undefined
[4] Universidad Central de Venezuela,undefined
[5] Trihealth’s Good Samaritan Hospital,undefined
[6] Albany Retina Consultants PLLC,undefined
来源
关键词
Autoimmune experimental uveitis; Biologic agents; Cytokines; Autoimmune disease; Immunosuppression;
D O I
暂无
中图分类号
学科分类号
摘要
Experimental uveitis models were developed in an effort to elucidate the pathogenesis of human uveitis. The therapeutic effects of numerous anti-inflammatory agents including corticosteroids and immunomodulatory agents including biologic response modifiers have been investigated in both experimental and human uveitis. Monoclonal antibodies to tumor necrosis factor alpha and anti-interleukins, among others, demonstrate efficacy and are employed in the treatment of uveitis refractory to conventional immunomodulatory agents.
引用
收藏
页码:145 / 156
页数:11
相关论文
共 50 条
  • [31] The critical points in induction of experimental autoimmune uveitis
    Klimova, Aneta
    Stangova, Petra Seidler
    Svozilkova, Petra
    Forrester, John V.
    Klaska, Izabela
    Heissigerova, Jarmila
    BIOMEDICAL PAPERS-OLOMOUC, 2016, 160 (01): : 140 - 142
  • [32] EPITOPES AND IDIOTYPES IN EXPERIMENTAL AUTOIMMUNE UVEITIS - A REVIEW
    DUA, HS
    ABRAMS, M
    BARRETT, JA
    GREGERSON, DS
    FORRESTER, JV
    DONOSO, LA
    CURRENT EYE RESEARCH, 1992, 11 : 59 - 65
  • [33] The Role of αA-Crystallin in Experimental Autoimmune Uveitis
    Wang, L.
    Zhang, L.
    Wang, Z. -F.
    Huang, Z. -X.
    Hu, X.
    Gong, L.
    Tang, X.
    Liu, F.
    Luo, Z.
    Ji, W.
    Hu, W. -F.
    Woodward, Z.
    Zhu, J.
    Liu, Y. -Z.
    Nguyen, Q. D.
    Li, D. W. -C.
    CURRENT MOLECULAR MEDICINE, 2015, 15 (06) : 558 - 564
  • [34] Protective effect of pristane on experimental autoimmune uveitis
    Daudin, Jean-Baptiste
    Monnet, Dominique
    Kavian, Niloufar
    Espy, Cecile
    Wang, Andrew
    Chereau, Christiane
    Goulvestre, Claire
    Omri, Samy
    Brezin, Antoine
    Weill, Bernard
    Batteux, Frederic
    Nicco, Carole
    IMMUNOLOGY LETTERS, 2011, 141 (01) : 83 - 93
  • [35] ADOPTIVE TRANSFER OF EXPERIMENTAL AUTOIMMUNE UVEITIS BY LYMPHOCYTES
    GERY, I
    MOCHIZUKI, M
    MCALLISTER, C
    KUWABARA, T
    ACTA OPHTHALMOLOGICA, 1984, : 57 - 57
  • [36] Targeting PEDF for the treatment of experimental autoimmune uveitis
    Zhang, Xiaomin
    Zhang, Zhihui
    Chen, Shuang
    Chen, Nu
    Ma, Jian-Xing
    Li, Xiaorong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [37] Gene therapy of experimental autoimmune uveitis (EAU).
    Caspi, RR
    Kang, Y
    Zambidis, E
    Scott, DW
    Chan, CC
    Agarwal, RK
    FASEB JOURNAL, 1999, 13 (05): : A992 - A992
  • [38] ULTRASTRUCTURAL PATHOLOGY OF EXPERIMENTAL AUTOIMMUNE UVEITIS IN THE RAT
    MCMENAMIN, PG
    FORRESTER, JV
    STEPTOE, R
    DUA, HS
    AUTOIMMUNITY, 1993, 16 (02) : 83 - 93
  • [39] EXPERIMENTAL AUTOIMMUNE UVEITIS IN THE ATHYMIC NUDE RAT
    SALINASCARMONA, MC
    NUSSENBLATT, RB
    GERY, I
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1982, 12 (06) : 480 - 484
  • [40] BIOLOGIC AGENTS IN AUTOIMMUNE RHEUMATIC DISEASES AND BONE HEALTH
    Athanassiou, L.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S102 - S102